3.99
+0.01(+0.25%)
Currency In USD
Previous Close | 3.99 |
Open | 3.93 |
Day High | 4.05 |
Day Low | 3.93 |
52-Week High | 5.92 |
52-Week Low | 0.52 |
Volume | 500,623 |
Average Volume | 1.16M |
Market Cap | 262.62M |
PE | -3.02 |
EPS | -1.32 |
Moving Average 50 Days | 4.21 |
Moving Average 200 Days | 2.38 |
Change | 0.01 |
If you invested $1000 in Neuronetics, Inc. (STIM) since IPO date, it would be worth $143.63 as of May 24, 2025 at a share price of $3.99. Whereas If you bought $1000 worth of Neuronetics, Inc. (STIM) shares 5 years ago, it would be worth $1,985.07 as of May 24, 2025 at a share price of $3.99.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month
GlobeNewswire Inc.
May 14, 2025 12:31 PM GMT
New national awareness day will foster greater understanding of transcranial magnetic stimulation (TMS) treatment The company will celebrate on social media, sharing patient and provider stories that highlight the impact NeuroStar has as a safe, effe
Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call
GlobeNewswire Inc.
Apr 22, 2025 12:30 PM GMT
MALVERN, Pa., April 22, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disor
Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression
GlobeNewswire Inc.
Mar 31, 2025 12:31 PM GMT
Policy update increases access for millions covered by Evernorth Health ServicesMALVERN, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company